NCT00423046 · Interventional trial
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
Overall registry status Completed
Phase 3
Conditions Infections, Papillomavirus, Papillomavirus Vaccines
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory